In vitro antagonism of beta-lactam antibiotics by cefoxitin. - Wikidata - wikimedia - TriplyDB

In vitro antagonism of beta-lactam antibiotics by cefoxitin.

In vitro antagonism of beta-lactam antibiotics by cefoxitin.

http://www.wikidata.org/entity/Q35676343

about

Kirby-Bauer disc approximation to detect inducible third-generation cephalosporin resistance in Enterobacteriaceae SHV-type extended-spectrum beta-lactamase production is associated with Reduced cefepime susceptibility in Enterobacter cloacae Comparison of ESBL--and AmpC producing Enterobacteriaceae and methicillin-resistant Staphylococcus aureus (MRSA) isolated from migratory and resident population of rooks (Corvus frugilegus) in Austria Diverse potential of beta-lactamase inhibitors to induce class I enzymes.Synergism of the combinations of imipenem plus ciprofloxacin and imipenem plus amikacin against Pseudomonas aeruginosa and other bacterial pathogens.Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients.Characterization of beta-lactamase induction in Enterobacter cloacae Development of resistance to cephalosporins in clinical strains of Citrobacter spp.Emergence of resistance to beta-lactam and aminoglycoside antibiotics during moxalactam therapy of Pseudomonas aeruginosa infections.High prevalence of extended-spectrum beta-lactamase-producing strains among blood isolates of Enterobacter spp. collected in a tertiary hospital during an 8-year period and their antimicrobial susceptibility patterns.In vitro activities of ICI 194008 and ICI 193428, two new cephem antimicrobial agents.Imipenem-induced resistance to antipseudomonal beta-lactams in Pseudomonas aeruginosa.Beta-lactamase stability of cefpirome (HR 810), a new cephalosporin with a broad antimicrobial spectrum.Resistance of Pseudomonas aeruginosa to new beta-lactamase-resistant beta-lactams.Effect of aztreonam in combination with azlocillin or piperacillin on Pseudomonas aeruginosa.Resistance caused by decreased penetration of beta-lactam antibiotics into Enterobacter cloacae Antagonism of carbenicillin and cefamandole by cefoxitin in treatment of experimental infections in mice.Transfer of the chromosomal bla gene from Enterobacter cloacae to Escherichia coli by RP4::mini-Mu Surgical antimicrobial prophylaxis: principles and guidelines.Recognition and clinical significance of mechanisms of bacterial resistance to beta-lactams.In vitro activities of ureidopenicillins alone and in combination with amikacin and three cephalosporin antibiotics.Significance of inducible cephalosporinase remaining in the experimentally infected rat granuloma pouch after beta-lactam therapy.Occurrence of extended-spectrum and AmpC β-lactamases in multiple drug resistant Salmonella isolates from clinical samples in Lagos, Nigeria Chromosomal beta-lactamases of Enterobacter cloacae are responsible for resistance to third-generation cephalosporins.Ampc Beta lactamases among gram negative clinical isolates from a tertiary hospital, South India.Influence of clindamycin on derepression of beta-lactamases in Enterobacter spp. and Pseudomonas aeruginosa Antimicrobial effect of beta-lactam antibiotic combinations against Bacteroides fragilis in vitro.Burden of different beta-lactamase classes among clinical isolates of AmpC-producing Pseudomonas aeruginosa in burn patients: A prospective study.Role of inducers in detection of blaPDC-mediated oxyimino-cephalosporin resistance in Pseudomonas aeruginosa.Multi-drug resistance in clinical isolates of Gram-negative bacilli in a tertiary care hospital of Assam The β-lactamase inhibitor avibactam (NXL104) does not induce ampC β-lactamase in Enterobacter cloacae.Combinations of beta lactam antibiotics.Interaction of mezlocillin and cefoxitin against Proteus morganii in the granuloma pouch model.Progress and challenges in implementing the research on ESKAPE pathogens.What do beta-lactamases mean for clinical efficacy?Rapid method for determining the beta-lactamase-inducing potency of drugs.Sensitivity of 523 blood culture isolates to 33 antibiotics.Prevalence, microbiology, and clinical characteristics of extended-spectrum beta-lactamase-producing Enterobacter spp., Serratia marcescens, Citrobacter freundii, and Morganella morganii in Korea

P2860

Q24794095-45F40F9A-A9DB-435B-B559-4635D7E750A1 Q34073514-84312ED9-CED5-41DD-9E46-CAD15380CC2E Q35082753-5E26CA92-10E1-41C4-93C0-78E3F751A0B1 Q35246938-C26B9DB8-E85B-4CA5-81F7-A36383E18445 Q35539176-1D6321D7-18F6-40D3-9519-DC867A7BB1BE Q35573306-451D31C8-8E64-49D9-ABFA-188FCD0D75A9 Q35739787-E112FD2A-A78A-41DB-9A82-88ADBA2AD795 Q35759876-5EAA6159-C134-4F97-9B4E-BA9A48E7D209 Q35761938-7BDC0968-AC0E-47BC-9532-68503CC25BC9 Q36670187-03AE2DBD-CA1D-4322-8D64-910DC3621E7B Q39832175-00CF216D-C5E1-4960-8566-A50810D7DA0E Q39834069-8A28843C-B62D-4846-95C6-4CF6C2618B93 Q39834956-08E837C2-ABBD-4405-8180-116FC8855E78 Q39849040-6A40A64D-F4D9-40C7-9D25-F45BA3319240 Q39849074-C451791C-5353-4083-87F9-16AD1D1BE78F Q39849656-D2EC14E8-CDDA-48B5-964A-74C64A3C212E Q39857268-A49DE12D-543A-4037-BF3F-407775DAE26F Q39967218-D2354231-0924-42EE-BE03-9183885359F8 Q40214971-189687B2-0325-4F17-958B-53E261D63D4A Q40215884-393E8EB7-63DF-403D-A6FE-764F174D4622 Q40283363-38F0CD0E-58F0-4021-A566-0F01100E3DE0 Q40284273-2C89B2EF-E8B2-4441-AAC8-29CE770B7AF7 Q40351171-C5A1E91C-7315-49D9-8548-47E3A34D4A6E Q41956941-1F68162F-ED9F-45ED-B110-42EB632429F3 Q42071028-12432D82-B76F-4325-87E9-7709B88E7AB1 Q42091897-7EB38658-74AF-4DE3-978A-471D0A5F5963 Q42147876-92849717-3A6F-47C8-8599-D1922536C7E7 Q42352716-BC99B9B7-8323-4342-B4DB-928D1C87F7AB Q42689550-ECA36DAA-E38F-4F4C-9F74-93B9BB69EDEA Q42717437-7DB40DF7-056E-423A-9A0B-1970E17FA9B2 Q42830303-5B11E261-3530-400C-AAC3-9FFB4FDB43BD Q43048864-63C5E94B-7F29-44B5-AE0F-89B2BD1D9570 Q43538663-88DD3249-C71A-4F97-957B-C58F1F620232 Q45710828-34625412-C6C1-4AD1-8838-86FB6F91B558 Q50212297-6104E06B-C362-4EC6-9DBE-F9D9E229959C Q54375920-6E431B6B-B30C-4047-A8EE-2235768DC842 Q54482265-7E27B6B6-6939-4FCE-89AA-4860D0303BFC Q57212092-5D54BC73-E21E-4840-B7B7-A29C8A4B26DD

P2860

In vitro antagonism of beta-lactam antibiotics by cefoxitin.

http://www.wikidata.org/entity/Q35676343

description

1982 nî lūn-bûn

@nan

1982年の論文

@ja

1982年論文

@yue

1982年論文

@zh-hant

1982年論文

@zh-hk

1982年論文

@zh-mo

1982年論文

@zh-tw

1982年论文

@wuu

1982年论文

@zh

1982年论文

@zh-cn

name

In vitro antagonism of beta-lactam antibiotics by cefoxitin.

@ast

In vitro antagonism of beta-lactam antibiotics by cefoxitin.

@en

type

label

In vitro antagonism of beta-lactam antibiotics by cefoxitin.

@ast

In vitro antagonism of beta-lactam antibiotics by cefoxitin.

@en

prefLabel

In vitro antagonism of beta-lactam antibiotics by cefoxitin.

@ast

In vitro antagonism of beta-lactam antibiotics by cefoxitin.

@en

P1433

Q35676343-7DFC34EF-5949-4C74-AE89-1583C38101A6

P1476

Q35676343-2A5B7C0E-EBFA-4100-B504-F0425442BB30

P2093

Q35676343-236BAAA2-7EF9-4B08-8DFC-7DFC34DD9FD4

Q35676343-8809DC6D-2F8E-45DF-812C-045B3C3195C6

Q35676343-D23BDE70-DB3E-4D73-8A4A-6A4F3676C4F8

P2860

Q35676343-0027EDB7-FE2F-4E66-B228-55D57A2B56A3

Q35676343-096E0EC7-C5F3-4978-87A8-DBDD3D6870D4

Q35676343-0E308399-FC6F-4945-9598-7D69E90566D8

Q35676343-1A260F32-F116-4C65-90FA-BE280FA35EC7

Q35676343-1DFA18C1-3FA5-4D70-88DF-6FA78F98E79E

Q35676343-3EDB0BDA-AAD3-43E5-9F6D-30DBA1EE6F9F

Q35676343-45BA60BF-E807-48CA-BF8A-A51FF2A31265

Q35676343-5CE209FB-31BE-4A08-8167-3F3E9768D562

Q35676343-5D6BB533-7F91-440E-AA0B-14838A3F11A9

Q35676343-629C390D-48C7-45B1-B579-F3623E25BBBE

P304

Q35676343-DD252772-EA80-4CC9-B6B8-0CD5050A3415

P31

Q35676343-988A6D1B-0F9A-4EAB-9334-17631309AFAA

P356

Q35676343-8D1B5D4E-4BE4-4802-A1E6-78157188A6AC

P407

Q35676343-813E0C51-84A2-42F7-95DF-6FCF7198FDD1

P433

Q35676343-ED68F42B-3A81-4A9E-AB4F-74D4A0A39F74

P478

Q35676343-6BE11F70-F207-444B-B247-6C9BC24BBEBA

P577

Q35676343-FFAB0641-7142-48AE-8DCB-0EB0B43F2CCF

P5875

Q35676343-3AE349E4-7777-44FE-B8B2-7DB0205AFDE4

P698

Q35676343-2888EB0C-5541-48B4-8A2E-A008B8DE2E0E

P921

Q35676343-F94E743E-D1C0-4F0B-94FF-5794B687056A

P932

Q35676343-09EE7059-DD44-4B76-80AB-4492E97494B8

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

In vitro antagonism of beta-lactam antibiotics by cefoxitin.

@en

P2093

Goering RV

http://www.w3.org/2001/XMLSchema#string

Sanders CC

http://www.w3.org/2001/XMLSchema#string

Sanders WE Jr

http://www.w3.org/2001/XMLSchema#string

P2860

Emergence of resistance to cefamandole: possible role of cefoxitin-inducible beta-lactamases

Properties of the penicillin-binding proteins of Escherichia coli K12,

In vitro antibacterial activity and susceptibility of cefsulodin, an antipseudomonal cephalosporin, to beta-lactamases.

Cefoxitin, a semisynthetic cephamycin antibiotic: resistance to beta-lactamase inactivation.

Spontaneous mutant with loss of beta-lactamase in Aerobacter cloacae

From penicillin-binding proteins to the lysis and death of bacteria: a 1979 view.

beta-lactamase stability of HR 756, a novel cephalosporin, compared to that of cefuroxime and cefoxitin.

Competition of beta-lactam antibiotics for the penicillin-binding proteins of Pseudomonas aeruginosa, Enterobacter cloacae, Klebsiella aerogenes, Proteus rettgeri, and Escherichia coli: comparison with antibacterial activity and effects upon bacteri

Cefoxitin, a semi-synthetic cephamycin: a microbiological overview.

In vitro and in vivo antibacterial effects of combinations of beta-lactam antibiotics.

P304

968-975

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.21.6.968

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

1982-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

16218411

http://www.w3.org/2001/XMLSchema#string

P698

6981376

http://www.w3.org/2001/XMLSchema#string

P921

P932

182054

http://www.w3.org/2001/XMLSchema#string